Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

Analysis paralysis – how to get the true measure of clinical trials

July 20, 2011 Research and Development Les Rose, clinical trials

The great physicist Lord Kelvin famously said: “When you can measure what you are speaking about, and express it in …
Feature

Future of AZ-BMS diabetes drug in doubt

July 20, 2011 Research and Development, Sales and Marketing AstraZeneca, BMS, dapagliflozin, diabetes, research and development news

A US advisory committee has rejected an investigational compound for type II diabetes sufferers, throwing its future into doubt. Dapagliflozin, …
News

Contract research news in brief

July 20, 2011 Research and Development research and development news

M&A abounds in the CRO sector with INC completing its purchase of Kendle, inVentiv snappig up Pharmanet and ICON buying …
News
ASCO 2011

ASCO 2011: news from the front line against cancer

July 18, 2011 Research and Development ASCO, Cancer, oncology

Pharmafocus presents selected highlights from the American Society of Clinical Oncology’s annual meeting in Chicago, beginning with non-small cell lung …
Feature

Lophius Biosciences expands management team

July 15, 2011 Manufacturing and Production, Research and Development appointment, manufacturing and production, research and development

German biotech Lophius Biosciences has made six senior management appointments ahead of a planned 2012 market entry move. The Regensburg-based …
Appointment

France cleans up regulation – and restricts pharma role

July 14, 2011 Research and Development, Sales and Marketing France, Mediator, Servier, pharmacovigilance, research and development news

France has unveiled sweeping changes to how it regulates prescription medicines following the scandal surrounding Servier’s Médiator. Health minister Xavier …
News

Paul Barrow joins CiToxLAB

July 14, 2011 Research and Development appointment, research and development

French CRO CiToxLAB has appointed Paul Barrow as director of scientific projects and client consulting. He joins the Evreux-based company, …
Appointment

Sanofi eyes phase III move for sarilumab in rheumatoid arthritis

July 13, 2011 Research and Development Regeneron, Sanofi, ankylosing spondylitis, research and development news, rheumatoid arthritis, sarilumab

Sanofi is poised to move sarilumab into phase III trials for rheumatoid arthritis after the monoclonal antibody showed positive results …
News
US Food and Drug Administration

Pharma regulators consult on drug development initiatives

July 13, 2011 Research and Development Companion Diagnostics, EMA, FDA, Pharmacogenomics, biomarkers, research and development news

Pharma regulators in the US and Europe have put out separate consultations on issues affecting how medicines are developed. The …
News
Amgen

Amgen collaborates on cancer antibody research

July 13, 2011 Research and Development Amgen, Cancer, TGF-beta monoclonal antibody, research and development news

Amgen has teamed up with German biotech Micromet to develop tumour-destroying antibodies in a two-year deal that could net Micromet …
News
clavis_pharma_nicholas_adams

Clavis Pharma appoints Nicholas Adams

July 13, 2011 Research and Development appointment, research and development

Norwegian cancer drug development company Clavis Pharma has appointed Nicholas Adams as chief business officer. He has more than 23 …
Appointment

Cellectis appoints Dr Andrew Scharenberg

July 12, 2011 Manufacturing and Production, Research and Development appointment, manufacturing and production, research and development

Paris-based genome engineering specialist Cellectis Therapeutics has appointed Dr Andrew Scharenberg as chief scientific officer. He is an attending physician …
Appointment

EMA plans adverse event reports for the public

July 12, 2011 Research and Development, Sales and Marketing EMA, adverse events, patient information

The EMA will start producing monthly adverse event reports for the public as part of its plans to open up …
News

Chiltern Announces New Legal Entity in Israel

July 11, 2011 Research and Development

 
News
Press release

Novartis’ Votubia reduces benign brain tumours in SEGA patients

July 11, 2011 Research and Development Novartis, SEGA, Votubia, everolimus

Novartis’ novel cancer drug Votubia has reduced the size of SEGA brain tumours in a late-stage trial. Votubia (or everolimus …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026